Greenland Mines Ltd. (NASDAQ: GRML) has finalized its acquisition of the Sarfartoq Nd-Pr Rare Earths Project in southwest Greenland, a strategic move that strengthens the company's position in the rare earth supply chain outside China. The transaction, valued at $20 million in cash and $15 million in securities, closed on Sept. 1, 2026, according to a press release. The project's planned annual production of neodymium-praseodymium (NdPr) oxide is expected to account for roughly 34% of all NdPr oxide refined outside China at 2025 consumption levels during each of its nine scheduled operating years.
The acquisition underscores the growing importance of diversifying rare earth sources, as NdPr is critical for permanent magnets used in electric vehicles and wind turbines. An independent Initial Assessment based solely on the ST1 deposit estimates a high-case pre-tax net present value (NPV) of approximately $2.05 billion and a pre-tax internal rate of return (IRR) of 118.6%, including Indicated and Inferred Mineral Resources. These figures highlight the project's potential economic significance.
With the acquisition complete, Greenland Mines is moving forward with a series of activities to advance Sarfartoq toward a Pre-Feasibility Study. These include targeted infill drilling, pilot-scale metallurgical test work, mine engineering planning, environmental and social baseline studies, and drone-based magnetic surveys. The company aims to de-risk the project and refine its technical and financial parameters.
Notably, Neo Performance Materials (TSX: NEO) has become a strategic shareholder in Greenland Mines through the transaction. Neo retains offtake rights for up to 60% of future Sarfartoq ore or mineral concentrate production for processing at its Silmet rare earth separation facility in Estonia. This partnership integrates Sarfartoq into a Western supply chain, enhancing its strategic value.
The closing of this acquisition aligns with Greenland Mines' broader vision of creating a North Atlantic Critical Metals Corridor, linking Greenland's mineral resources with allied downstream jurisdictions. The company operates two divisions: Mining, which includes the Skaergaard Project in southeast Greenland and now Sarfartoq, and Biotech, which focuses on Klotho’s KLTO-202 for ALS. This multi-asset platform provides exposure to rare earth magnet materials, precious metals, and selected midstream processing opportunities.
For investors, this development signals Greenland Mines' commitment to becoming a significant player in the rare earth sector, with a project that could contribute meaningfully to global NdPr supply outside China. The company's progress on Sarfartoq will be closely watched as it moves toward a Pre-Feasibility Study, which will provide more detailed insights into the project's viability.
As the project advances, Greenland Mines is poised to benefit from the increasing demand for rare earth elements driven by the global energy transition. The successful closing of the acquisition and the planned next steps underscore the company's strategic execution and its potential to deliver long-term value.
